Novavax Inc. has submitted an application to Switzerland’s drugs regulator for the authorization of its COVID-19 vaccine in adults, the U.S. vaccine maker said on Monday. The submission is based on data from two key clinical trials in the United States and Mexico as well as in the UK that showed the vaccine was 90…
Novavax Applies for COVID-19 Vaccine Approval in Switzerland
February 14, 2022
admin
approvalBusiness & EconomyCCP VirusCompaniesCOVID-19EuropeNovavaxSwitzerlandVaccineVaccines & SafetyWorld
0 Comment
Novavax Rollout in Australia to Begin One Week Earlier
Australia will begin rolling out the Novavax COVID-19 vaccine at select general practices, community pharmacies, and state clinics across the country for Australians aged 18 and over from Feb. 14, one week earlier than planned. It is the first protein-based vaccine approved for Australians, allowing people who have allergies to certain ingredients used in approved…
Novavax Underdelivers on COVID-19 Vaccine Promises
Novavax Inc. has delivered just a small fraction of the 2 billion COVID-19 shots it plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower income countries such as the Philippines, public officials involved in their government’s vaccine roll-outs told Reuters. Novavax said it has completed delivery of…
UK Approves Its First Protein-Based COVID-19 Vaccine, From Novavax
The United Kingdom approved its first protein-based COVID-19 vaccine, made by Novavax. The vaccine, called Nuvaxovid (generic name NVX-CoV2373), is the fifth COVID-19 vaccine authorized by the Medicines and Healthcare products Regulatory Agency (MHRA), the U.K.’s independent medicines regulator. Other COVID-19 vaccines authorized for use in the U.K. include those from Pfizer/BioNTech, Moderna, Johnson & Johnson, and…
Novavax Passes First Hurdle for New Zealand Vaccine Rollout
New Zealand is one step closer to rolling out the Novavax protein-based COVID-19 vaccine called Nuvaxovid, with the country’s medicines regulator, Medsafe, granting provisional approval for the vaccine to be used in adults aged 18 and over. Announcing the decision on Feb. 4, Chris James, group manager for Medsafe, said the organisation had worked tirelessly to…
Novavax Seeks FDA Emergency Authorization for COVID-19 Vaccine
Novavax announced Monday it has formally submitted a request to the U.S Food and Drug Administration (FDA) to grant emergency use authorization (EUA) for its two-dose vaccine, NVX-CoV2373, for people 18 years and older. If granted, NVX-CoV2373 would become the fourth COVID-19 vaccine to be made available in the United States. Currently available COVID-19 vaccines are…
Novavax Vaccines to Become Available In Australia Late February
Australia is set to roll out its first protein-based COVID-19 vaccine from Feb. 21, with federal Health Minister Greg Hunt saying that the Australian Technical Advisory Group on Immunisation (ATAGI) had given the government the go-ahead for the country’s fourth COVID-19 vaccine. Hunt said that Australia’s first shipment of the vaccine would undergo a detailed batch testing…
Australia Approves Novavax COVID-19 Vaccine and New COVID Oral Drug Treatments
January 19, 2022
admin
AustraliaAustralian Technical Advisory Group on ImmunisationCCP VirusCOVID-19 vaccineGreg HuntInternationalLagevrioNovavaxoral pillsPaxlovidPfizerTherapeutic Goods AdministrationVaccines & SafetyWorld
0 Comment
The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19. The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s…
95 Percent of Eligible Australians Over 16 Have Received One Dose of COVID-19 Vaccine
Australian Health Minister Greg Hunt has announced that 95 percent of eligible Australians aged over 16 have received a first dose of a vaccine against COVID-19. Hunt said the milestone had gone beyond almost all predictions made at the outset of the pandemic. “We have achieved the 95 percent vaccination rate that is often referred…
Novavax Files Final Data to FDA, Lays Groundwork for COVID-19 Vaccine EUA Request in a Month
Novavax announced it has submitted the final round of data on its COVID-19 vaccine to the U.S. Food and Drug Administration (FDA) in anticipation of submitting a request to the agency for emergency use authorization (EUA) in a month. The final data is related to the vaccine’s manufacturing processes, and its submission is the final prerequisite…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`